“Syndromic testing based on multiplex PCR will facilitate identifying more pathogens, thereby providing comprehensive approaches to disease diagnosis,” says Bae. “It will help clinicians to ...
2 个月
GlobalData on MSNRoche’s STI assay panels gain FDA 510(k) clearance and CLIA waiverfor its cobas liat sexually transmitted infection (STI) multiplex assay panels. Tests for chlamydia and gonorrhoea (CT/NG) ...
Roche (OTCQX:RHHBY) has received FDA clearance with a CLIA waiver for its cobas liat sexually transmitted infection, or STI, multiplex assay ... The tests, which use PCR technology, can deliver ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果